Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells. [electronic resource]
Producer: 20190826Description: 2378-2388 p. digitalISSN:- 2473-9537
- Animals
- Apoptosis -- genetics
- Biomarkers
- Calreticulin -- genetics
- Cell Differentiation -- drug effects
- Enzyme Inhibitors -- pharmacology
- Hematopoietic Stem Cells -- drug effects
- Janus Kinase 2 -- genetics
- Mice
- Mice, Knockout
- Mice, Transgenic
- Myeloid Progenitor Cells -- drug effects
- Oligonucleotides -- pharmacology
- Primary Myelofibrosis -- drug therapy
- Telomerase -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.